Cierra N. Sharp

Cierra N. Sharp

Aug 15, 2016

Group 6 Copy 1
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Little penguins in a big city: How will St Kilda's little penguins cope with increased El Niño years?

    There is a large colony of little penguins in the trendy suburb of St Kilda, Melbourne, Australia. These penguins...

    Is a newly discovered parasite negatively impacting bay scallops in North Carolina?

    My fellow researchers and I have discovered a new digenean trematode parasite in bay scallop populations on...

    Backer Badge Funded